University Hospital Southampton NHS Foundation Trust
uhs.nhs.ukTotal trials
147
Active
36
Phase 3
2
Total enrollment
119,462
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Oxygen | — | — | — | — | — | 1 | |
| R-CHOP + acalabrutinib | — | — | — | — | — | 2 | |
| R-CHOP | — | — | — | — | — | 1 | |
| Nivolumab | — | — | — | — | — | 1 | |
| Ch14.18/CHO | — | — | — | — | — | 1 | |
| Ferric derisomaltose | — | — | — | — | — | 1 | |
| Vancomycin | — | — | — | — | — | 1 |
Next readouts
- 2025-06-30
- 2026-02
- 2026-12
- 2027-03
- 2027-11
Top conditions
- Cardiac Arrest6
- Asthma5
- Heart Failure4
- Diffuse Large B Cell Lymphoma4
- Critical Illness4
- Malnutrition4
- Depression3
- COVID3
Frequently asked questions about University Hospital Southampton NHS Foundation Trust
- How many clinical trials does University Hospital Southampton NHS Foundation Trust have on ClinicalTrials.gov?
- University Hospital Southampton NHS Foundation Trust is listed as the lead sponsor on 147 clinical trials in ClinicalTrials.gov, 36 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital Southampton NHS Foundation Trust's trials are in Phase 3?
- 2 of University Hospital Southampton NHS Foundation Trust's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University Hospital Southampton NHS Foundation Trust focus on?
- University Hospital Southampton NHS Foundation Trust's most-studied conditions on ClinicalTrials.gov are Cardiac Arrest, Asthma, Heart Failure, Diffuse Large B Cell Lymphoma, Critical Illness.
- When are University Hospital Southampton NHS Foundation Trust's next clinical trial readouts?
- University Hospital Southampton NHS Foundation Trust has 5 upcoming primary-completion readouts tracked here; the soonest is “Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma”, expected around 2025-06-30.